FDA

Current sort has key articles at the top. Click on "Article Date" to sort by date, click on specific "tag" to view all articles in that category.

Title Tags Notes
Warning Letters and Test Results for Cannabidiol-Related Products FDA, warning

Over the past several years, FDA has issued several warning letters to firms that market unapproved new drugs that allegedly contain cannabidiol (CBD). As part of these actions, FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. It is important to note that these products are not approved by FDA for the diagnosis, cure, mitigation, treatment, or prevention of any disease. Consumers should beware purchasing and using any such products.

Drug Made From Cannabis Plant Gets Backing From FDA Staff gw pharm, Epidiolex, seizure, FDA

The treatment, which GW Pharma hopes to market under the name Epidiolex, is produced in the U.K. from a plant that has been bred to have a high cannabidiol, or CBD, content, Chief Executive Officer Justin Gover said in an interview earlier this month. The chemical is purified and made into a strawberry-flavored oral solution, he said.

FDA APPROVES SYNTHETIC LIQUID MARIJUANA COMPOUND FDA, Prescription, dronabinol

The FDA just approved a new, synthetic THC product for use in treating a variety of ailments, in liquid form. But despite being the first liquid THC replacement on the market, this may not be worth the buzz.

5 reasons marijuana is not medicine medicine, madras, FDA

To approve a medicine, the FDA requires five criteria to be fulfilled...marijuana legalization via ballot amendments or legislative bills does not meet any of the FDA requirements. 
Smoking dope, getting high and saying I feel better is not a criteria for medicine. 

Is Medical Marijuana Really A Miracle Cure? FDA, Medical

“Individuals considering cannabinoids as a possible treatment for their symptoms should discuss the potential benefits and harms with their doctor,” said Penny Whiting of University Hospitals Bristol NHS Foundation Trust in the UK.

Federal Judge Refuses to Reschedule Marijuana Under Controlled Substances Act madras, Medical, FDA

Five legal standards are:

  1. Does marijuana have a known and reproducible drug chemistry?
  2. Does marijuana have adequate safety studies?
  3. Are there adequate and controlled studies showing marijuana’s efficacy?
  4. Are marijuana’s therapeutic benefits accepted by qualified experts?
  5. Are scientific data available for scrutiny?

To sustain the view that marijuana should remain in Schedule I, the prosecution team also had to show that marijuana has:

  1. A high potential for abuse,
  2. No currently accepted medical use in treatment in the United States, and
  3. Unacceptable safety standards for its use under medical supervision.
Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function Cystic Fibrosis, FDA, Research
Subscribe to FDA